- What "Training" Means for the DACVCP
- The Residency Pathway to Phase I
- Phase I: The Science Foundation You Must Train On
- Phase II: Applied Therapeutics, Design and Regulation
- Training for the Phase II Credentials Package
- Rehearsing the Remote ExamSoft Format
- Sequencing Your Preparation Around the Domains
- Timeline, Eligibility Window and Fees
- After Training: Who Hires and What Comes Next
- Frequently Asked Questions
- DACVCP training means approved ACVCP residency work plus two sequential exams: Phase I (200 multiple-choice questions) and Phase II (ten question groups, 200...
- Phase II requires two peer-reviewed papers accepted or published by February 1 of the exam year, at least one first-authored.
- Both phases must be passed within a five-year eligibility window starting the first eligible exam year after Phase I approval.
- The 2026 exams were delivered remotely through ExamSoft's Examplify, so rehearse the software well before test day.
What "Training" Means for the DACVCP
The Diplomate, American College of Veterinary Clinical Pharmacology (DACVCP) is a specialty credential administered by the American College of Veterinary Clinical Pharmacology (ACVCP). Unlike a certification you can pick up after a prep course and a single sitting, the DACVCP is built around structured residency training, a two-phase examination sequence, and a research-publication requirement. "Training" therefore covers three tracks running in parallel: supervised clinical pharmacology residency, scientific output, and examination preparation.
If you are still orienting yourself to the credential itself, start with What Is DACVCP? and DACVCP Requirements 2026: Eligibility, Prerequisites & How to Qualify. This article focuses on what the training path actually demands and how to organize it.
The Residency Pathway to Phase I
To sit for Phase I, applicants must be legally qualified to practice veterinary medicine and be enrolled in, or have completed, approved ACVCP residency training. The Phase I application requires two references. ACVCP describes both institutional residency programs and alternate approved training routes on its Becoming a Resident and Residency Training Programs pages, and it publishes broad residency learning outcomes. Those outcomes describe what a resident should be able to do; they are not an exam-domain count, so do not treat them as a substitute for the exam content headings.
What to confirm early in residency
- Program approval status: verify that your institutional or alternate route is approved by ACVCP before you invest years in it.
- First-year registration: ACVCP's Becoming a Resident page references a USD 75 first-year candidate registration fee. The public pages do not make clear whether this is the same as, or additional to, the USD 75 Phase I application charge, so ask ACVCP directly rather than assuming.
- Research planning: because Phase II requires two papers, project design should begin in the first year, not the last.
Phase I: The Science Foundation You Must Train On
Phase I is 200 multiple-choice questions delivered in two 100-question sessions, ordinarily 08:00-12:00 and 14:00-18:00 local time. That is eight active examination hours, excluding the midday break. The content headings below come from ACVCP's Suggested Blueprint for Phase I (last revised December 2021). They are a dated preparation curriculum, not a verified current or exhaustive outline, and the current Phase I blueprint could not be retrieved for verification. Treat them as a strong study scaffold and confirm against ACVCP's current materials. The full list is walked through in DACVCP Exam Domains 2026: Complete Guide to All 26 Content Areas.
Core Principles Block (Domains 1-9)
These nine headings are the conceptual engine of the whole credential. Weakness here will cost you across every organ-system topic later.
- Physiochemical characteristics of active pharmaceutical ingredients (note the source spelling "Physiochemical"): ionization, lipophilicity and solubility as they drive absorption and distribution
- Pharmacodynamics: receptor theory, dose-response relationships, agonism and antagonism
- Drug movement and Pharmacokinetics: membrane transport, compartmental and non-compartmental reasoning, clearance, volume of distribution, half-life
- Factors impacting drug movement and/or drug response: species, age, disease state, genetics, drug interactions
- Routes of administration and Dosing forms (and relevant drug delivery devices)
- Adverse events and Causes for therapeutic failure
Organ-System and Drug-Class Block (Domains 10-22)
Here the principles are applied to systems and drug families. Expect questions that require you to connect mechanism, disposition and toxicity within a given system.
- Nervous System, Renal, Cardiovascular, Gastrointestinal, Reproduction, Endocrine
- General and special senses (a heading candidates often under-prepare)
- Control of inflammation/immunomodulation and Anticancer drugs
- Fluid therapy and Anti-infectives
- Botanical/Herbals and Disinfectants/antiseptics, two niche areas that are easy to neglect and therefore easy to lose points on
Because the 22 Phase I headings are unweighted in the retained source, you cannot rank them by exam percentage. Allocate time according to your own gap analysis rather than guessing at weights. Our DACVCP Study Guide 2026 and DACVCP Cheat Sheet 2026 can help you structure review.
Phase II: Applied Therapeutics, Design and Regulation
Phase II is a different kind of examination. It has ten question groups using written responses, multiple choice, fill-in-the-blank and extended matching, worth 200 points across two 100-point sessions, with an ordinary schedule of eight active hours. Note that 200 is a point total, not a question count. The current Phase II Examination page lists four subject categories, though it does not publish current category percentages:
- Therapeutics
- Pharmacokinetics and Therapeutic Drug Monitoring
- Experimental Design, Statistics and Analytical Methods
- Regulatory Pharmacology
A separately indexed Suggested Blueprint for Phase II (December 2021) contains historical question allocations. Those are not converted here into current percentages and should not be treated as the current format. The current Phase II blueprint itself could not be retrieved during verification.
How Phase II training differs
Written-Response Fluency
Written responses reward the ability to construct a defensible clinical or scientific argument, not merely recognize a correct option.
- Practice writing dosing-regimen rationales from first principles
- Practice critiquing a study design, naming its biases and proposing a better analysis
- Practice explaining a regulatory pathway and its evidentiary requirements in structured prose
This is where training diverges most from Phase I. A resident who has memorized receptor tables but never written a protocol, analyzed a pharmacokinetic dataset, or read a regulatory submission will find Phase II uncomfortable. Seek those experiences deliberately during residency.
Training for the Phase II Credentials Package
Phase II eligibility is not just an exam seat. You need completed approved training, a Phase I pass, approved credentials, course documentation and transcripts, and two peer-reviewed papers accepted or published by February 1 of the examination year. The requirements for the papers are specific:
- At least one paper must be original veterinary clinical pharmacology research.
- The other may be original research or an eligible evidence-based systematic review/meta-analysis.
- First authorship is required on at least one paper.
- Neither paper may have been used for another specialty board.
- Publication must not predate the beginning of training by more than two years.
Credentials applications are ordinarily due October 1 before the examination year, with intent to sit due February 1. The currently dated checklist covers October 1, 2025 and February 1, 2026; check ACVCP for the cycle you are targeting.
Rehearsing the Remote ExamSoft Format
ACVCP's published 2026 administration was remote: Phase I on May 19 and Phase II on June 30, both using ExamSoft. Those dates have passed, and a 2027 schedule was not verified, so check DACVCP Exam Dates 2026 and ACVCP's Candidate Information page for the next cycle. This dated notice takes precedence over generic phase-page references to a testing location or on-site practice.
Technical readiness is part of training here:
- Candidates supply a compatible Windows or Mac laptop running Examplify, with administrator privileges.
- The encrypted exam is downloaded in advance and unlocked with a proctor password.
- Examination mode blocks internet access, files and other applications.
- Advance practice examinations are available to rehearse the software and become familiar with question structure.
Key Takeaway
Run the ExamSoft practice exam early on the exact laptop you will use. Software problems on a day with eight active exam hours are the most preventable way to lose composure.
Sequencing Your Preparation Around the Domains
Generic study techniques matter less than ordering. Here is a DACVCP-specific sequence that builds each layer on the one beneath it, assuming roughly a year before Phase I.
Principles first
- Physiochemical characteristics, Pharmacodynamics, Drug movement, Pharmacokinetics
- Work calculation problems by hand until clearance and volume of distribution are intuitive
Modifiers and failure modes
- Factors impacting drug movement/response, Routes, Dosing forms
- Adverse events and Causes for therapeutic failure, since these tie principles to clinical reasoning
Organ systems and drug classes
- Nervous, Renal, Cardiovascular, Gastrointestinal, Reproduction, Endocrine, Senses
- Inflammation/immunomodulation, Anticancer, Fluid therapy, Anti-infectives
Niche topics and timed rehearsal
- Botanical/Herbals and Disinfectants/antiseptics
- Full 100-question timed blocks using the ExamSoft practice environment
After Phase I, shift emphasis to Therapeutics, Pharmacokinetics and Therapeutic Drug Monitoring, Experimental Design, Statistics and Analytical Methods, and Regulatory Pharmacology, and add written-response practice. For more on the difficulty curve, see How Hard Is the DACVCP Exam?
Timeline, Eligibility Window and Fees
Both phases must be passed within a five-year eligibility period that begins with the first eligible examination year after Phase I approval. ACVCP's example: approval in December 2025 permits the 2026-2030 examinations. This is an examination eligibility window, not credential renewal.
| Item | Published 2026-cycle amount |
|---|---|
| Phase I application | USD 75 |
| Phase I examination | USD 200 |
| Phase II credentials review | USD 250 |
| Phase II examination | USD 300 |
Retakes require the respective examination fee. The general fee page permits refunds only for extenuating circumstances accepted by the Board, while the phase pages describe examination fees as nonrefundable. Plan as though fees are not recoverable. For a fuller breakdown, see DACVCP Certification Cost 2026.
After Training: Who Hires and What Comes Next
Clinical pharmacologists typically work where drug disposition, dosing and regulation intersect: veterinary teaching hospitals and colleges, pharmaceutical and animal-health industry, contract research organizations, and regulatory or governmental settings. The Phase II categories of Pharmacokinetics and Therapeutic Drug Monitoring, Experimental Design, Statistics and Analytical Methods, and Regulatory Pharmacology map closely onto the skills these employers want. For role-specific detail, see DACVCP Jobs, and for the financial side, DACVCP Salary Guide 2026 and Is the DACVCP Certification Worth It?
Maintenance of certification
ACVCP's current Committees page confirms that a Maintenance of Certification committee administers recertification. Historical bylaws (approved June 2018) describe review of maintenance records every two years toward maintenance at ten years, but the complete legacy file was not retrieved and its current applicability is unverified. No current renewal hours, fees or interval should be inferred from it. Confirm directly with ACVCP.
If you want to pressure-test your knowledge while you train, our practice test site offers exam-style question drills you can use alongside your residency study.
Frequently Asked Questions
Yes. Phase I requires that you be legally qualified to practice veterinary medicine and enrolled in or have completed approved ACVCP residency training, delivered through an institutional program or an approved alternate route.
Phase I has 200 multiple-choice questions in two 100-question sessions. Phase II has ten question groups using written responses, multiple choice, fill-in-the-blank and extended matching, worth 200 points across two 100-point sessions. Both ordinarily provide eight active hours.
Two peer-reviewed papers accepted or published by February 1 of the examination year. At least one must be original veterinary clinical pharmacology research and at least one must be first-authored. Neither may have been used for another specialty board.
Five years, beginning with the first eligible examination year after Phase I approval. ACVCP's example is approval in December 2025 permitting the 2026-2030 examinations. This is an exam eligibility window, not a renewal period.
Not necessarily. The 22 Phase I headings come from a Suggested Blueprint last revised December 2021, and the current Phase I and Phase II blueprints could not be retrieved for verification. Use the headings as a study scaffold and confirm current content with ACVCP.